Quote | Avita Medical Inc. (NYSE:RCEL)
Last: | $ |
---|---|
Change Percent: | -2.16% |
Open: | $10.72 |
Close: | $10.44 |
High: | $10.8249 |
Low: | $10.15 |
Volume: | 705,544 |
Last Trade Date Time: | 02/12/2020 04:43:59 pm |
News | Avita Medical Inc. (NYSE:RCEL)
2024-03-25 06:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
VALENCIA, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced it has submitted its response to the U.S. Food and D...
Message Board Posts | Avita Medical Inc. (NYSE:RCEL)
Subject | By | Source | When |
---|---|---|---|
When I responded to your post..i meant that | Noseyrosey | investorshub | 04/20/2023 4:56:08 PM |
I hope you are correct but so far | dndodd | investorshub | 04/20/2023 3:42:07 PM |
I dont think so! | Noseyrosey | investorshub | 04/20/2023 12:12:29 PM |
This offering will probably not be good for | dndodd | investorshub | 04/18/2023 1:17:55 PM |
https://seekingalpha.com/news/3956749-avita-medical-files-for-200m-mixed-shelf-o | MONYMAN3 | investorshub | 04/15/2023 1:41:31 AM |
News, Short Squeeze, Breakout and More Instantly...
Avita Medical Inc. Company Name:
RCEL Stock Symbol:
NYSE Market:
2024-03-25 06:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
VALENCIA, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced it has submitted its response to the U.S. Food and D...
VALENCIA, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ:RCEL, ASX: AVH)), a commercial-stage regenerative medicine compa...